Cetera Investment Advisers Amarin Corp Plcuk Transaction History
Cetera Investment Advisers
- $49.2 Billion
- Q1 2025
A detailed history of Cetera Investment Advisers transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Cetera Investment Advisers holds 10,964 shares of AMRN stock, worth $119,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,964
Previous 15,780
30.52%
Holding current value
$119,507
Previous $7,000
1300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$271 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$135 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$37.1 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$28.6 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$27.4 Million5.52% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.39B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...